Sara Tolaney, MD, MPH | Authors


A Study Investigating Pembrolizumab in Combination With Eribulin in TNBC

January 03, 2017

Sara Tolaney, MD, MPH, associate clinical research director of Breast Oncology at the Dana-Farber Cancer Institute in Boston, discusses a clinical trial investigating pembrolizumab in combination with eribulin in triple-negative breast cancer.